Rana Fadhil Mousa

High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments

Arafat Hussein Al-Dujaili, Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim et al. · Schizophrenia Bulletin · 2020 · 65 citations · Full text

A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina

Rana Fadhil Mousa, Hasan Najah Smesam, Hasan Abbas Qazmooz et al. · CNS Spectrums · 2021 · 30 citations

Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates

Rana Fadhil Mousa, Hussein Kadhem Al‐Hakeim, Amer Fadhil Alhaideri et al. · Metabolic Brain Disease · 2020 · 26 citations

Psychoneuroimmunology, Opioid System Correlates, Psychiatry +13

Trace element, immune and opioid biomarkers of unstable angina, increased atherogenicity and insulin resistance: Results of machine learning

Hasan Abbas Qazmooz, Hasan Najah Smesam, Rana Fadhil Mousa et al. · Journal of Trace Elements in Medicine and Biology · 2020 · 22 citations

Inflammation, Metabolic Syndrome, Biomarker (Medicine) +13

In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy

Hussein Kadhem Al‐Hakeim, Rana Fadhil Mousa, Arafat Hussein Al-Dujaili et al. · Metabolic Brain Disease · 2021 · 12 citations

Cognitive Science, Neuropsychology, Psychiatry +13